IMR Press / CEOG / Volume 40 / Issue 1 / pii/1630388025925-656875731

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Origianal Research
Arterial hypertension and female sexual dysfunction in postmenopausal women
Show Less
1 Department of Obstetrics, Gynaecology and Reproductive Sciences - Second University of Naples, Naples (Italy)
Clin. Exp. Obstet. Gynecol. 2013, 40(1), 58–60;
Published: 10 March 2013

Purpose: To evaluate female sexual dysfunction in hypertensive postmenopausal women and the effects of antihypertensive therapy. Materials and Methods: Female sexual dysfunction was assessed by the Female Sexual Function Index (FSFI) in three groups of postmenopausal patients: normotensive women (group A: 240 women), hypertensive women without therapy (group B: 220 women), hypertensive women on therapy (group C: 80 women). Results: The incidence of female sexual dysfunction was increased in group B compared to groups A and C. Healthy patients showed higher FSFI scores compared to hypertensive patients (groups B and C). Hypertensive-treated patients accounted for higher scores in all items compared to hypertensive patients without therapy. Conclusions: Essential hypertension significantly affects female sexual function. Physicians should recognize and properly manage FSD in hypertensivewomen.
Female sexual dysfunction
Antihypertensive therapy
Back to top